Our Portfolio

NuvOx Pharma is a clinical-stage pharmaceutical company developing a drug that improves the flow of oxygen from lungs to blood and from blood to tissue.

Our mission is to reverse hypoxia. Hypoxia occurs when the body’s cells don’t get enough oxygen, this plays a significant role in various fatal diseases. We are committed to patient safety and ensuring their access to life-saving oxygen therapeutics.

Over 30 animal studies have shown therapeutic effects in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).